KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Capital Employed (2021 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Return on Capital Employed for 5 consecutive years, with 0.07% as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Return on Capital Employed rose 23.0% year-over-year to 0.07%, compared with a TTM value of 0.07% through Mar 2025, up 23.0%, and an annual FY2024 reading of 0.0%, up 21.0% over the prior year.
  • Return on Capital Employed was 0.07% for Q1 2025 at Aurinia Pharmaceuticals, up from 0.01% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.07% in Q1 2025 and bottomed at 0.57% in Q3 2021.
  • Average Return on Capital Employed over 5 years is 0.2%, with a median of 0.19% recorded in 2023.
  • The sharpest move saw Return on Capital Employed soared 31bps in 2022, then increased 5bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.44% in 2021, then skyrocketed by 42bps to 0.26% in 2022, then rose by 25bps to 0.19% in 2023, then soared by 95bps to 0.01% in 2024, then soared by 739bps to 0.07% in 2025.
  • Business Quant data shows Return on Capital Employed for AUPH at 0.07% in Q1 2025, 0.01% in Q4 2024, and 0.07% in Q3 2024.